Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
**THIS IS NOT A DERAMP** (Disclaimer in case little fanboy slinkey gets upset again - I'll only see a green box anyway).
I'm sure many would of noticed the news of ODX launching the Mologic ELISA test this morning.
Does pose the question of where our ELISA is and why manufacturing and distribution partners haven't been signed up yet given we thought it was ready to go 4 months ago? Is it being sold? We don't know...
I repeat, the IP, pipeline, future potential of Avacta far outweigh anything else in my PF, but there is some very pertinent questions for the BOD's to answer with regard to the status of all Covid related diagnostic products IMO.. No doubt we shall get answers soon!
I'd suggest the thread itself is actually very worthy of a mention given our ties with Abingdon and some of the recent discussions around a UK testing consortium etc.
Again, I simply don't understand the very childish comments aimed at anyone trying to have an informed debate. I wasn't being negative, deramping etc etc - was merely asking some questions, to which PL75 has provided one very sensible, logical response.
In any case, your posting history reads like a 10 year olds playground argument - take a look before commenting on the merits of other posters content.
Whilst I agree, surely what they state within the RNS does pour at least some scorn over some of the theories being suggested here over the last week or two. i.e. Govnt consortium with Avacta at the forefront, securing most of the capacity at ODX, BBI and Abingdon etc. Why would they procure for manufacture this overseas test, amongst others, and in doing so use up capacity, if bucket loads of govnt subsidised orders were about to come their way...
I don't know, still a LTH and believer here, but the "look at the silence from ODX, Abingdon etc" as well as Avacta argument in reference to testing solutions is no longer valid. I get the UK is only the tip of the iceberg in terms of the global market, but surely we need an update, or at least an indication, of where we sit ASAP, especially given the BOD's apparent strategy of focusing largely on the UK market to date....
https://www.londonstockexchange.com/news-article/ABDX/trading-update/14840047
“Contract manufacturing for partners” paragraph an interesting read. The specific tests mentioned wouldn’t appear to be Avacta.
ODX news today also, come on Al!!!
Zoom, this is obviously the key question.
My view, FWIW, is that we are either on the cusp of gold and some huge announcements with HMG, OR, we have made very little to no progress since the aforementioned RNS..
I lean towards the former, given the recent soundbites from media, UK RTC etc, coupled with the fact I refuse to believe the BOD's comms can be this bad unless for very good reason.
Only time will tell.
https://aptamergroup.com/aptamer-group-and-cytiva-form-new-collaboration-for-the-development-of-covid-19-rapid-test/
Let's hope Cytiva do as poor a job for Aptamer as they did for us if it's a straight shoot out....(given need for capacity I'm not sure it is...)
https://avacta.com/avacta-and-mologic-enter-research-and-product-development-collaboration-agreement/
I know this is old news and been discussed before, but given Mologic would be the other obvious sovereign LFT, is there any chance their device is using affimers.....?
I hear ya Craig. And agreed, feels like we've been here before many times, but surely now on the cusp of knowing one way or the other.....I just don't see how we're not involved given the scale of sovereign LFT's needed....they need all capacity....
Slinkey - I think unfair to call me a doom and gloom merchant frankly...... I've had some grumbles and can often be glass half full, especially on the lack of tangible news flow we've had, but certainly never been on the deramp etc. As I say, unfair if you fully read my posting history IMO.
J4ms, to address your points:
- I agree we're overdue and it's been frustrating. But look at the negative press down swamping the Innova test. Clear AS wanted to get this bang on and not damage our reputation long term, especially given the IP involved. Hard to disagree with his logic there IMO.
- I think there was definitely issues with setting up the saliva test for mass production, however in retrospect I honestly think the pivot to AN was due to directive from UK gov. Again, hard to disagree with this given it now appears we have a scalable device.
- Share sale definitely frustrating and worrying at the time, more so given subsequent lack of news. However, all to be forgiven if he delivers in coming months.
- BAMS I agree is a weird one given how long it's been in validation. However, Gov.uk website specifics an unnamed mass spec machine has indeed been validated. Given I'm only aware of two, strong chance it is ours. I also think it's becoming increasingly obvious that NDA's are indeed at play here. I have been repeatedly sceptical about this, but recent news would appear to suggest I was wrong. BAMS delay could very well be part of this.
All the best.